Caribou Biosciences
Transformative therapies development
Next-generation CRISPR genome editing
allogeneic CAR-T cell therapies
oncology
autoimmune
About Caribou Biosciences
Caribou Biosciences is a leading clinical-stage CRISPR genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. Our next-generation genome-editing technology enables superior precision to develop cell therapies that are armored to potentially improve activity against diseases. We are advancing our pipeline of off-the-shelf cell therapies from our CAR-T cell therapy platform as readily available treatments for patients with hematologic malignancies and autoimmune diseases.
Jobs at Caribou Biosciences (3)
- $265k-$280k
- United States
- $230k-$280k
- Worldwide
- $200k-$225k
- United States